avanafil

Phase 3

Vivus (INVA)

Phase 3

Development Phase

Upcoming Catalysts

Historical Events

Regulatory Approvals

No Catalysts Found

No catalyst events have been recorded for this drug yet.

Competitive Landscape

2 competitors in Erectile Dysfunction

JNJDapoxetine

Phase 3

LLYtadalafil once a day [T(OaD)]

Phase 3

View Full Landscape

Drug Information

Target Indication

Erectile Dysfunction

Clinical Trial

NCT00809471

Last updated: 12/23/2025

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Source: FDA Orange Book

Regulatory Approvals

EMA6/21/2013

Spedra

Treatment of erectile dysfunction in adult men. In order for Spedra to be effective, sexual stimulation is required.

View on EMA

Drug Science

Mechanism of action & safety profile

Developer

INVA

Vivus

Pharmaceutical Preparations•North America•NASDAQ

Related Pipeline

VI-0521Phase 3

Obesity

VI-1121Phase 2

Alzheimer's Disease

Phentermine/TopiramatePhase 2

Diabetes

Topical alprostadil (PGE-1)Phase 2

Sexual Dysfunction, Physiological

VI-0609Phase 2

Lymphoma

View full pipeline

Get Catalyst Alerts

Receive weekly digests of upcoming catalysts